Jazz Pharmaceuticals Director Jennifer Cook Receives RSU Award

What Happened

• Jennifer E. Cook, a director of Jazz Pharmaceuticals plc (JAZZ), was granted 1,605 restricted stock units (RSUs) on August 5, 2026. The RSUs were awarded at a grant price of $0.00 (no cash paid) and represent a contingent right to receive one ordinary share per unit upon vesting. The units are scheduled to vest in full on July 23, 2027, subject to her continued service and certain conditions.

Key Details

• Transaction date: August 5, 2026; Form filed August 7, 2026 (timely filing).
• Transaction type/code: Award/Grant (A) — restricted stock units.
• Units granted: 1,605 RSUs; grant price reported as $0.00 (typical for RSU awards).
• Vesting: Units vest in full on July 23, 2027, subject to continuous service and additional conditions (per the 2007 Amended and Restated Non-Employee Directors Stock Award Plan).
• Shares owned after transaction: Not specified in this Form 4 filing.
• No 10b5-1 plan, tax withholding, sale, or exercise reported in this filing.

Context

• This is an equity compensation award for a non-employee director, not an open-market purchase or sale. RSUs are contingent grants that convert to shares only upon vesting and therefore do not indicate an immediate cash investment or liquidity event. Such grants are common as part of director compensation and should be interpreted as compensation rather than a direct buy/sell signal.